Intravitreal corticosteroids for diabetic macular edema: a network meta-analysis of randomized controlled trials

被引:0
|
作者
Lu Gao
Xu Zhao
Lei Jiao
Luosheng Tang
机构
[1] The Second Xiangya Hospital,Department of Ophthalmology
[2] Central South University,Department of Ophthalmology
[3] The First Affiliated Hospital of Guangzhou Medical University,Department of Anesthesiology
[4] The Second Xiangya Hospital,School of Medicine
[5] Central South University,undefined
[6] Taizhou University,undefined
来源
关键词
Diabetic macular edema; Corticosteroids; Triamcinolone acetonide; Fluocinolone acetonide; Dexamethasone; Best-corrected visual acuity; Central macular thickness; Intraocular pressure; Network meta-analysis; Randomized controlled trial;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Intravitreal corticosteroids for diabetic macular edema: a network meta-analysis of randomized controlled trials
    Gao, Lu
    Zhao, Xu
    Jiao, Lei
    Tang, Luosheng
    [J]. EYE AND VISION, 2021, 8 (01)
  • [2] Intravitreal bevacizumab with or without triamcinolone acetonide for diabetic macular edema: a meta-analysis of randomized controlled trials
    Liu Xiangdong
    Zhou Xiaodong
    Wang Zhi
    Li Tao
    Jiang Bo
    [J]. 中华医学杂志(英文版), 2014, (19) : 3471 - 3476
  • [3] Intravitreal bevacizumab with or without triamcinolone acetonide for diabetic macular edema: a meta-analysis of randomized controlled trials
    Liu Xiangdong
    Zhou Xiaodong
    Wang Zhi
    Li Tao
    Jiang Bo
    [J]. CHINESE MEDICAL JOURNAL, 2014, 127 (19) : 3471 - 3476
  • [4] The Efficacy and Safety of Dexamethasone Intravitreal Implant for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta-Analysis of Randomized Controlled Trials
    Li, Xiaodong
    Xie, Xuejun
    [J]. JOURNAL OF OPHTHALMOLOGY, 2022, 2022
  • [5] Intravitreal corticosteroid implant vs intravitreal ranibizumab for the treatment of macular edema: a meta-analysis of randomized controlled trials
    Wei, Qingquan
    Chen, Rui
    Lou, Qiyang
    Yu, Jing
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 301 - 307
  • [6] SYSTEMIC SAFETY OF RANIBIZUMAB FOR DIABETIC MACULAR EDEMA Meta-analysis of Randomized Trials
    Yanagida, Yasuko
    Ueta, Takashi
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (04): : 629 - 635
  • [7] Intravitreal triamcinolone versus intravitreal bevacizumab for diabetic macular edema:a meta-analysis
    Xiao-Ling Zhang
    Jian Chen
    Ri-Jia Zhang
    Wen-Jie Wang
    Qing Zhou
    Xiao-Yan Qin
    [J]. International Journal of Ophthalmology, 2013, (04) : 546 - 552
  • [8] Intravitreal triamcinolone versus intravitreal bevacizumab for diabetic macular edema: a meta-analysis
    Zhang, Xiao-Ling
    Chen, Jian
    Zhang, Ri-Jia
    Wang, Wen-Jie
    Zhou, Qing
    Qin, Xiao-Yan
    [J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2013, 6 (04) : 546 - 552
  • [9] Intravitreal Ranibizumab (Lucentis) for the Treatment of Diabetic Macular Edema: A Systematic Review and Meta-Analysis of Randomized Clinical Control Trials
    Wang, Haiyan
    Sun, Xiaodong
    Liu, Kun
    Xu, Xun
    [J]. CURRENT EYE RESEARCH, 2012, 37 (08) : 661 - 670
  • [10] Aflibercept for diabetic macular oedema: a Meta-analysis of randomized controlled trials
    Chu Luan Nguyen
    Lindsay, Andrew
    Wong, Eugene
    Chilov, Michael
    [J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2018, 11 (06) : 1002 - 1008